• Cash balance of €8.2 million at 30 June 2025
• Net cash outflow of €4.0 million during the quarter
• Secured two new customers through Baxter sales channel
• Expanded support for AI-powered virtual care platforms

Oneview Healthcare Plc released its Appendix 4C Quarterly Cashflow report for the quarter ending 30 June 2025 (Q2 25). The company's cash balance at 30 June 2025 was €8.2 million (A$14.7m), compared to €12.2 million (A$21.0m) at 31 March 2025. The company had a net cash outflow of €4.0 million during the quarter, compared to an outflow of €3.2 million in the same quarter of the prior year. This was primarily due to marginally higher operating spend, including one-off restructuring costs of €234k, as well as unfavourable timing and quantum of R&D tax credit receipts. The company maintained strong momentum in adding new customers, securing two new customers through the Baxter sales channel. The sales pipeline remains robust, with multiple late-stage opportunities expected to close in the coming months. Implementation projects also progressed at existing customer sites. Oneview announced several upcoming innovations, including expansion of virtual care support, next-generation personalization, real-time visibility and workflow coordination, and data-driven performance tracking and benchmarking. The company is confident about the seasonally stronger second half of 2025.

The company has had a solid start to the year and continues to enjoy a very significant pipeline of new opportunities in the US, both directly and via the Baxter channel. The maturity of the pipeline is developing at a solid pace and augurs well for the signing of new logos in the second half of 2025. The company is confident about the seasonally stronger second half with its AI innovation strategy and market positioning.